Stromal disrupting effects of nab-paclitaxel in pancreatic cancer von Alvarez, R, Musteanu, M, Garcia-Garcia, E, Lopez-Casas, P P, Megias, D, Guerra, C, Muñoz, M, Quijano, Y, Cubillo, A, Rodriguez-Pascual, J, Plaza, C, de Vicente, E, Prados, S, Tabernero, S, Barbacid, M, Lopez-Rios, F, Hidalgo, M

Volltext

Precision medicine in NSCLC and pathology: how does ALK fit in the pathway? von Kerr, K M, López-Ríos, F

Volltext

IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer von Cortés-Sempere, M, de Miguel, M P, Pernía, O, Rodriguez, C, de Castro Carpeño, J, Nistal, M, Conde, E, López-Ríos, F, Belda-Iniesta, C, Perona, R, de Caceres, I Ibanez

Volltext

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer von Ibanez de Caceres, I, Cortes-Sempere, M, Moratilla, C, Machado-Pinilla, R, Rodriguez-Fanjul, V, Manguán-García, C, Cejas, P, López-Ríos, F, Paz-Ares, L, de CastroCarpeño, J, Nistal, M, Belda-Iniesta, C, Perona, R

Volltext

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens von Gonzalez de Castro, D, Angulo, B, Gomez, B, Mair, D, Martinez, R, Suarez-Gauthier, A, Shieh, F, Velez, M, Brophy, V H, Lawrence, H J, Lopez-Rios, F

Volltext

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research von Marchiò, C., Scaltriti, M., Ladanyi, M., Iafrate, A.J., Bibeau, F., Dietel, M., Hechtman, J.F., Troiani, T., López-Rios, F., Douillard, J.-Y., Andrè, F., Reis-Filho, J.S.

Volltext

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors von Bamias, Aristotelis, Merseburger, Axel, Loriot, Yohann, James, Nicholas, Choy, Ernest, Castellano, Daniel, Lopez-Rios, F, Calabrò, Fabio, Kramer, Mario, de Velasco, Guillermo, Zakopoulou, Roubini, Tzannis, Kimon, Sternberg, Cora N

Volltext

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours von Garrido, P., Hladun, R., de Álava, E., Álvarez, R., Bautista, F., López-Ríos, F., Colomer, R., Rojo, F.

Volltext

Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification von Angulo, B, Suarez-Gauthier, A, Lopez-Rios, F, Medina, PP, Conde, E, Tang, M, Soler, G, Lopez-Encuentra, A, Cigudosa, JC, Sanchez-Cespedes, M

Volltext

Biomarkers in pancreatic ductal adenocarcinoma von Gallego, J., López, C., Pazo-Cid, R., López-Ríos, F., Carrato, A.

Volltext

Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers von Conde, E., Angulo, B., Izquierdo, E., Paz-Ares, L., Belda-Iniesta, C., Hidalgo, M., López-Ríos, F.

Volltext

Composite anatomical―clinical―molecular prognostic model in nonsmall cell lung cancer von LOPEZ-ENCUENTRA, A, LOPEZ-RIOS, F, GONZALEZ-PONT, G, ASTUDILLO-POMBO, J, MATE-SANZ, J. L, FREIXINET, J, ROMERO-SAAVEDRA, T, SANCHEZ-CESPEDES, M, GOMEZ DE LA CAMARA, A, CONDE, E, GARCIA-LUJAN, R, SUAREZ-GAUTHIER, A, MANES, N, RENEDO, G, DUQUE-MEDINA, J. L, GARCIA-LAGARTO, E, RAMI-PORTA, R

Volltext

Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoa... von Gómez Dorronsoro, M. L., Vera, R., Ortega, L., Plaza, C., Miquel, R., García, M., Díaz, E., Ortiz, M. R., Pérez, J., Hörndler, C., Villar, C., Antúnez, J., Pereira, S., López-Rios, F., González-Cámpora, R.

Volltext

Lack of efficiency of precision oncology with target-based investigational treatments for patients in early phase clinical trials based on pre-screened molecular alterations von Doger de Spéville, B., Moreno, V., Hernandez, T., Boni, V., de Miguel, M.J., Rojo, F., Lopez-Rios, F., Calvo, E.

Volltext

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer von CARRETERO, J, MEDINA, P. P, SANCHEZ-CESPEDES, M, BLANCO, R, SMIT, L, TANG, M, RONCADOR, G, MAESTRE, L, CONDE, E, LOPEZ-RIOS, F, CLEVERS, H. C

Volltext

Reply to comment by Normanno et al on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’ von de Castro, D G, Lopez-Rios, F

Volltext

SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expressi... von Bamias, A., Merseburger, A.S., Loriot, Y., James, N., Choy, E., Castellano, D., Lopez-Rios, F., Calabrò, F., Kramer, M., de Velasco, G., Zakopoulou, R., Tzannis, K., Sternberg, C.N.

Volltext

MS17.01 Role of Liquid Biopsy in the Pathology Diagnosis Workflow (Including DNA, RNA Ad Exosomes) von Lopez-Rios, F.

Volltext

A Prospective Pilot Study of Target-guided Personalized Chemotherapy with Intensity-modulated Radiotherapy in Patients With Early Rectal Cancer von CUBILLO, Antonio, HERNANDO-REQUEJO, Ovidio, PRADOS, Susana, QUIJANO, Yolanda, HIDALGO, Manuel, GARCIA-GARCIA, Elena, RODRIGUEZ-PASCUAL, Jesús, DE VICENTE, Emilio, MORELLI, Pía, RUBIO, Carmen, LOPEZ-RIOS, Fernando, MURO, Avertano, LOPEZ, Ulpiano

Volltext

Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer’ von Alvarez, R, Musteanu, M, Garcia-Garcia, E, Lopez-Casas, P P, Megias, D, Guerra, C, Muñoz, M, Quijano, Y, Cubillo, A, Rodriguez-Pascual, J, Plaza, C, de Vicente, E, Prados, S, Tabernero, S, Barbacid, M, Lopez-Rios, F, Hidalgo, M

Volltext